Two protein-tyrosine kinases, Bruton's tyrosine kinase (Btk) and Syk, and m
embers of the protein kinase C (PKC) subfamily of serine/threonine kinases
play crucial roles in signal transduction through antigen receptors in B ly
mphocytes and high-affinity IgE receptors (Fc epsilon RI) in mast cells. Th
e present study provides genetic, biochemical, and pharmacological evidence
that, on Fc epsilon RI stimulation, Syk regulates Btk, and Btk selectively
regulates the membrane translocation and enzymatic activity of PKC beta I
among the conventional PKC isoforms (alpha, beta I, and beta II) expressed
in mast cells. Syk/Btk-mediated PKC beta I regulation is involved in transc
riptional activation of the IL-2 and tumor necrosis factor or genes through
the JNK pathway induced by FceRI stimulation. Accordingly, Fc epsilon RI-i
nduced production of these cytokines is inhibited by specific inhibitors of
Btk and Syk, as well as broad-specificity inhibitors of PKC and a selectiv
e inhibitor of PKC beta. Specific regulation of PKC beta I by Btk is consis
tent with the selective association of Btk with PKC beta I. Components of t
his signaling pathway may represent an attractive set of potential targets
of pharmaceutical interference for the treatment of allergic and other immu
nologic diseases.